FDA Issues Warnings About Unapproved "Chelation" Drugs

Eight companies warned about unsubstantiated claims, told to stop selling these drugs
By Beth Gilbert
HealthDay Reporter

FRIDAY, Oct. 15 (HealthDay News) -- The U.S. Food and Drug Administration has notified health care professionals and consumers that no evidence has proved that nonprescription "chelation" products actually rid the body of toxic metals and can treat a variety of serious conditions and diseases.

On Oct. 14, the FDA warned eight companies -- World Health Products LLC, Hormonal Health LLC, Evenbetternow LLC, Maxam Nutraceutics/Maxam Laboratories, Cardio Renew Inc., Artery Health Institute LLC, Longevity Plus, and Rhonda Henry, M.D. -- to stop selling their chelation products, as making unsubstantiated claims is a violation of federal law.

The FDA stated that these companies have not proved that their products are safe and effective in treating a variety of serious conditions and diseases, including autism spectrum disorder, cardiovascular disease, macular degeneration, and Parkinson's disease. The agency also recognizes that some of these companies say that their products can detect heavy metals in the body, which has not been substantiated. Nonprescription chelation products come in a variety of forms, including sprays, suppositories, capsules, liquid drops, and clay baths.

"FDA says consumers should avoid non-prescription products offered for chelation or detoxification," according to an FDA consumer update. "FDA-approved chelating agents are available by prescription only and are approved for use in specific indications such as the treatment of lead poisoning and iron overload. The agency says even the prescription medications carry significant risks, and they should only be used with medical supervision."

More Information

Copyright © 2010 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events